Provider review
Care Bare Rx review
Oral tirzepatide as well as injectable — but no price before the quiz.
Very few programs offer that molecule without a needle; almost none make you complete an intake to see what it costs.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated July 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
From $199/mo*
Visit Care Bare RxPrice as published
Care Bare Rx
From $199/mo*
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
If measuring a partial syringe is the part you dread, Care Bare Rx sells oral tirzepatide as well as injectable, plus oral Rybelsus and a brand-name pathway — an unusually wide set of ways to take a small amount, and oral tirzepatide in particular is rare. It is certified and HIPAA compliant. What it will not do is tell you the price: one advertised figure is shared across every weight-loss treatment on the platform, and per-dose rates appear only once you are through the intake quiz. No clinicians, founding year or parent company are disclosed, and there is no published monitoring program.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You specifically want tirzepatide without a needle
- You want oral Rybelsus and a brand-name pathway available from the same platform
- You are willing to complete an intake to find out what you would pay
Look elsewhere if
- You want a per-molecule price before handing over your details
- You want named clinicians and a disclosed operating entity
- You want lab work or monitoring as part of the program
What it actually costs
Price as published
From $199/mo*
- Vs median
- $30/mo above the $169 median across the 261 of 407 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
54 of the 407 programs here price a small dose this way. One advertised figure shared across every weight-loss treatment, with per-dose rates appearing only after the intake quiz.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
What it does well
- Oral tirzepatide as well as injectable — very few programs offer that molecule without a needle
- Oral Rybelsus and a brand Ozempic pathway sit beside the compounded line
- LegitScript certified and HIPAA compliant
Pharmacy, labs and oversight
Care Bare Rx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Care Bare Rx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
A LegitScript-certified, HIPAA-compliant multi-service platform bundling weight loss with hair, TRT, sexual health and NAD+. For a low-dose reader the relevant part is route: it carries oral tirzepatide as well as injectable, plus oral Rybelsus and a brand Ozempic pathway — an unusually wide set of ways to take a small amount. The cost is transparency: one "from $199/mo" covers every weight-loss treatment, and per-dose prices only appear once you are through the intake quiz.
The honest cons
No per-molecule price — the advertised $199 is shared across all weight-loss treatments and per-dose rates are quiz-gated
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
- No named clinicians, founding year or parent company disclosed
- No published lab or monitoring program
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Care Bare Rx is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Care Bare Rx does. Both are partners: we may earn a commission if you start care through these links.
Partner
Wellorithm
Pricing not published
No low-dose price published
Partner
HumeCare+
$199–$299/mo (gated)
No low-dose price published
Where this sits
#38 of 407
Ordered with the companies that pay us first, and Care Bare Rx is not one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Microdosing tirzepatide
- Oral semaglutide (Rybelsus)
- What the evidence actually shows
- Microdose & reconstitution calculator
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Oak
$250–$300/mo
- Vs median
- $81/mo above the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Oak review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.